ERBB2 and neoplasm: Although cost and turnaround time was greater for FISH, patients with tumor scores interpreted as 2+ by IHC would benefit from FISH to assess HER-2/neu more accurately status and avoid inaccurate prognostication and inappropriate treatment (31).